✦ LIBER ✦

MEN1 gene mutation analysis of high-grade neuroendocrine lung carcinoma

✍ Scribed by Larisa V. Debelenko; Jennifer I. Swalwell; Michael J. Kelley; Elisabeth Brambilla; Pachiappan Manickam; Galina Baibakov; Sunita K. Agarwal; Allen M. Spiegel; Stephen J. Marx; Settara C. Chandrasekharappa; Francis S. Collins; William D. Travis; Michael R. Emmert-Buck

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 106 KB
Volume: 28
Category: Article
ISSN: 1045-2257
DOI: 10.1002/(sici)1098-2264(200005)28:1<58::aid-gcc7>3.0.co;2-2

No coin nor oath required. For personal study only.

✦ Synopsis

Neuroendocrine tumors of the lung consist of a spectrum of neoplasms, including typical carcinoids, atypical carcinoids, large-cell neuroendocrine carcinomas (LCNEC), and small-cell lung carcinomas (SCLC). We previously reported frequent inactivation of the gene responsible for multiple endocrine neoplasia type 1 (MEN1) in both typical and atypical carcinoid tumors. In the present study, we extend the analysis of human NE lung tumors to include 9 primary SCLCs, 36 SCLC cell lines, and 13 primary LCNECs for MEN1 gene inactivation. In SCLC, loss of heterozygosity (LOH) at the MEN1 gene on chromosome band 11q13 was detected in one primary tumor and two cell lines. The coding sequence and splice junctions of the MEN1 gene were screened for mutations in all 44 tumors and cell lines, and no mutations were detected. Northern blot analysis of 13 SCLC cell lines showed the MEN1 transcript to be present and of normal size. In LCNECs, a somatic frameshift in the MEN1 gene (1226delC) was found in one of 13 tumors, representing the first mutation observed outside the spectrum of neoplasms associated with MEN1. Interestingly, neither a deletion nor a mutation was detected in the other allele, and wild-type mRNA sequence was expressed in the tumor, suggesting that the MEN1 gene was not inactivated by a conventional two-hit mechanism. The data support the hypothesis that SCLC and lung carcinoids develop via distinct molecular pathways; however, further investigation is necessary to determine the significance of the MEN1 gene mutation observed in a single case of LCNEC.

📜 SIMILAR VOLUMES

MEN1 Gene mutation analysis of sporadic

MEN1 Gene mutation analysis of sporadic adrenocortical lesions

✍ Birgit Görtz; Jürgen Roth; Ernst J.M. Speel; Akiko Krähenmann; Ronald R. De Krij 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 432 KB 👁 1 views

To clarify the role of the MEN1 gene in the tumorigenesis of sporadic adrenocortical tumors, we performed a molecular study on 35 adrenocortical lesions including 6 hyperplasias, 19 adenomas and 10 carcinomas. Loss of heterozygosity (LOH) of the MEN1 gene was assessed by PCR using an intragenic (D11

Mutation analysis of the MEN1 gene in Is

Mutation analysis of the MEN1 gene in Israeli patients with MEN1 and familial isolated hyperprolactinemia

✍ Orit Jakobovitz-Picard; David Olchovsky; Meir Berezin; Azizela Ghodsizade; Zvi Z 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Multiple endocrine neoplasia type 1 (MEN-1) is characterized by hyperfunction and tumor formation of the parathyroids, anterior pituitary and endocrine pancreas. We carried out exon-specific, PCR-based DNA sequencing of the coding exons of the MEN1 gene in 8 Israeli MEN1 patients: 4 familial and 4 s

Analysis of recurrent germline mutations

Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families

✍ Sunita K. Agarwal; Larisa V. Debelenko; Mary Beth Kester; Siradanahalli C. Guru; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder that manifests as varying combinations of tumors of endocrine and other tissues (parathyroids, pancreatic islets, duodenal endocrine cells, the anterior pituitary and others). The MEN1 gene is on chromosome 11q13; it was re

Mutation analysis of the MEN1 gene in Be

Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases

✍ Jacques Poncin; Roger Abs; Brigitte Velkeniers; Maryse Bonduelle; Marc Abramowic 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 2 views

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by tumors in parathyroids, enteropancreatic endocrine tissues, anterior pituitary, and other tissues. The gene for MEN1 has recently been cloned and shown to code for a 610-amino acid protein of enigmatic func

Exhaustive mutation analysis of the NF1

Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects

✍ Ludwine M. Messiaen; Tom Callens; Geert Mortier; Diane Beysen; Ina Vandenbroucke 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant disorders and is caused by mutations in the NF1 gene. Mutation detection is complex due to the large size of the NF1 gene, the presence of pseudogenes and the great variety of possible lesions. Although there is no evidence

Differential expression of the neuroendo

Differential expression of the neuroendocrine genes Hel-N1 and HuD in small-cell lung carcinoma: Evidence for down-regulation of HuD in the variant phenotype

✍ Peter H. King 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 125 KB 👁 2 views

Hel-NI and HuD belong to the elav gene family and have gained recent attention as potential neuroendocrine markers for small-cell lung carcinoma (SCLC). Members of this conserved family normally appear at different stages of neuronal maturation, raising the possibility that their expression patterns